Recce Pharmaceuticals Ltd (ASX:RCE)
Australia · Delayed Price · Currency is AUD 0.5200
-0.0250 (-4.59%)
Jun 3, 2026, 3:59 PM AEST
Recce Pharmaceuticals Market Cap
Recce Pharmaceuticals has a market cap or net worth of 150.38 million as of June 3, 2026. Its market cap has increased by 97.91% in one year.
Market Cap
150.38M
Enterprise Value
150.82M
Revenue
974.56K
Ranking
n/a
PE Ratio
n/a
Stock Price
0.52
Market Cap Chart
Since January 15, 2016, Recce Pharmaceuticals's market cap has increased from 20.55M to 150.38M, an increase of 631.85%. That is a compound annual growth rate of 21.12%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 3, 2026 | 150.38M | -20.00% |
| Dec 31, 2025 | 187.97M | 67.15% |
| Dec 31, 2024 | 112.46M | 3.19% |
| Dec 29, 2023 | 108.98M | -7.28% |
| Dec 30, 2022 | 117.53M | -34.34% |
| Dec 31, 2021 | 179.00M | -2.33% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Starpharma Holdings | 317.97M |
| Orthocell | 204.19M |
| Actinogen Medical | 136.47M |
| Nyrada | 120.03M |
| Island Pharmaceuticals | 108.01M |
| Dimerix | 105.07M |
| Alterity Therapeutics | 97.88M |
| Arovella Therapeutics | 85.82M |